Redesign Science is a pioneering brand that excels in simulating biomolecular systems using physics-based atomic-level molecular dynamics. Their groundbreaking NUVO™ technology combines the power of physics simulation with generative AI to drive their internal therapeutics pipeline. Redesign Science specializes in developing small molecule Targeted Protein Interaction Modulators (TPIM™), which enable unprecedented control over cellular biology.

They target the structural protein interactome to gain insights into the complexities of biological pathways and disease mechanisms, ultimately leading to groundbreaking advancements in medicine. With their integrated physics, chemistry, and synthetic data platform, NUVO™, Redesign Science has made rapid progress in multiple first-in-class targeted therapy programs. The brand is actively recruiting theoretical and computational chemists to continue advancing their physics-based technology.

Redesign Science is at the forefront of innovation, bridging the gap between basic science and the development of transformative technologies to tackle emerging challenges in healthcare